Tag Archives: patent

American Invents Act Strategies Highlighted at the IPCC Conference

Saravitz_David-NEW

By David Saravitz, Alston + Bird Day 2 of the 2012 BIO Intellectual Property Counsels’ Committee (IPCC) Spring Conference kicked off with a panel on the America Invents Act (AIA).  The panel focused on how practitioners and the U.S. Patent & Trademark Office (USPTO) are dealing with various provisions of this new patent act. Mr. Ira Finkelstein, Senior Patent Counsel with Baxter Healthcare, led off the session initially discussing the first-inventor-to-file provision of the AIA (§ Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

Biotech Patent Case Law Updates at the IPCC

cox-john

By John W. Cox, Counsel at Alston+Bird LLP The Spring 2012 BIO Intellectual Property Counsels’ Committee (IPCC) Conference, held in Austin, Texas, provided an excellent forum for intellectual property (IP) practitioners in the biotech industry to socialize, network, and participate in panel discussions focusing on the dynamic developments in the patent laws.  The conference began for the general participants over margaritas and Tex-Mex fare, where attendees were already discussing recent Supreme Court and Federal Circuit decisions Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: ,

Congressional Hearing on International Patent Issues: BIO Submits Comments

ipday_2012 (2)

The House Judiciary Committee conducted a hearing on World IP Day on “International Patent Issues: Promoting a Level Playing Field for American Industry Abroad.”  BIO submitted written comments for the record highlighting the unique patenting challenges that biotechnology companies face around the world. “To fully understand what is needed to level the playing field for the biotechnology sector in international markets, one must understand the intellectual property (IP) needs of the biotechnology sector.  Biotechnology innovation Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , ,

BIO Convention 2012: Biotech IP and Tech Transfer Sessions

US PTO

Recent court decisions and ongoing implementation of the America Invents Act are certain to impact the life sciences industry. The 2012 BIO International Convention will feature an educational track devoted to Biotech Patenting and Tech Transfer to discuss legal and legislative developments and how they are likely to impact biotech companies.   This year’s global event for biotechnology will take place June 18-21, 2012 at the Boston Convention and Exhibition Center in Boston, MA. Recent Developments Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , ,

New Patented Drugs Save Us All Money and Help Those in Dire Need

Money and Savings

New patented drugs actually save the United States and its citizens lots of money. In fact, new drugs save 7 times more in non-drug spending than they cost.  Those savings come as new drugs result in reduced hospital and nursing home admissions which far exceed the cost of using newer drugs.  New patented prescription drugs can also reduce the need for expensive surgeries and hospital stays. This data clearly articulates that the cost of treating Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , ,